Investors
This section contains information about Orion as an investment.
Stock exchange releases
- 3/1/2024 Orion Corporation: Transfer of 150,118 own B shares on 1 March 2024
- 2/26/2024 Orion Group Financial Statement documents 2023, Corporate Governance Statement and Remuneration Report published
- 2/13/2024 Notice to the Annual General Meeting of Orion Corporation
- 2/13/2024 Orion Group Financial Statement Release January–December 2023
Press releases
- 2/22/2024 Orion and Save the Children Finland announce cooperation to promote well-being of children in Finland and globally
- 2/19/2024 Orion to investigate the possible outsourcing of its pharmaceutical production in Kuopio, Finland
- 1/29/2024 Orion publishes Financial Statement Release for 2023 and holds a webcast on 13 February 2024
- 1/29/2024 Orion Corporation and Newel Health enter into licensing agreement for a digital therapeutic (DTx) ODD-403 (“Rohkea”) in pain